Presentation is loading. Please wait.

Presentation is loading. Please wait.

NICD1 immunohistochemical staining in normal and tumor tissue.

Published byRatna Sutedja Modified over 5 years ago

Similar presentations

Presentation on theme: "NICD1 immunohistochemical staining in normal and tumor tissue."— Presentation transcript:

1 NICD1 immunohistochemical staining in normal and tumor tissue.
NICD1 immunohistochemical staining in normal and tumor tissue. A and B, normal tonsil tissue with nuclear staining in suprabasal epithelial layer. C and D, tumor tissue with nuclear staining in peripheral pattern, sparing outermost layer. E and F, tumor tissue with nuclear staining in nonperipheral pattern. G and H, tumor tissue with negative staining in tumor cells. Magnification: B, ×10; A, C to H, ×20. Eleni M. Rettig et al. Cancer Prev Res 2015;8: ©2015 by American Association for Cancer Research

Download ppt "NICD1 immunohistochemical staining in normal and tumor tissue."

Similar presentations

25(OH)D and 1,25(OH)2D perfusion treatment effect on cancer-related markers: IF stains illustrating expression levels for Ki-67 (A), cyclin D1 (B), ErbB-2.

25(OH)D and 1,25(OH)2D perfusion treatment effect on cancer-related markers: IF stains illustrating expression levels for Ki-67 (A), cyclin D1 (B), ErbB-2.
Figure 3 Immunohistochemical analyses of positive and negative Epstein-Barr virus (EBV) control tissues using immunostaining Immunohistochemical analyses.

Figure 3 Immunohistochemical analyses of positive and negative Epstein-Barr virus (EBV) control tissues using immunostaining Immunohistochemical analyses.
IHC staining of FFPE esophageal tissues in tissue microarrays (×20).

IHC staining of FFPE esophageal tissues in tissue microarrays (×20).
Representative 3-generation pedigrees for serous cancer probands suggestive of inherited cancer susceptibility. Representative 3-generation pedigrees for.

Representative 3-generation pedigrees for serous cancer probands suggestive of inherited cancer susceptibility. Representative 3-generation pedigrees for.
High-throughput analysis of informative CpG sites for the four studied tumor suppressor genes (A-D). High-throughput analysis of informative CpG sites.

High-throughput analysis of informative CpG sites for the four studied tumor suppressor genes (A-D). High-throughput analysis of informative CpG sites.
Metformin decreases mTORC1 activity in the basal layer of oral epithelial dysplasias and mitotic activity in the hyperplastic epithelium. Metformin decreases.

Metformin decreases mTORC1 activity in the basal layer of oral epithelial dysplasias and mitotic activity in the hyperplastic epithelium. Metformin decreases.
A CHEK2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast Cancer  Pia Vahteristo, Jirina Bartkova, Hannaleena Eerola, Kirsi Syrjäkoski,

A CHEK2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast Cancer  Pia Vahteristo, Jirina Bartkova, Hannaleena Eerola, Kirsi Syrjäkoski,
Phosphorylation of TRIO Y2681 in human colorectal cancer (CRC) is correlated with poorer prognosis. Phosphorylation of TRIO Y2681 in human colorectal cancer.

Phosphorylation of TRIO Y2681 in human colorectal cancer (CRC) is correlated with poorer prognosis. Phosphorylation of TRIO Y2681 in human colorectal cancer.
Possible sites of action of aspirin in the prevention of colorectal cancer. Possible sites of action of aspirin in the prevention of colorectal cancer.

Possible sites of action of aspirin in the prevention of colorectal cancer. Possible sites of action of aspirin in the prevention of colorectal cancer.
SIRT1 is downregulated in human gastric cancer (GC).

SIRT1 is downregulated in human gastric cancer (GC).
BCX suppresses lung tumor, α7-nAChR expression, and α7-nAChR signaling in the NNK-treated mice. BCX suppresses lung tumor, α7-nAChR expression, and α7-nAChR.

BCX suppresses lung tumor, α7-nAChR expression, and α7-nAChR signaling in the NNK-treated mice. BCX suppresses lung tumor, α7-nAChR expression, and α7-nAChR.
Metformin and rapamycin decreased tumor weights in obese prediabetic mice. Metformin and rapamycin decreased tumor weights in obese prediabetic mice. A:

Metformin and rapamycin decreased tumor weights in obese prediabetic mice. Metformin and rapamycin decreased tumor weights in obese prediabetic mice. A:
TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor tissues. TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor.

TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor tissues. TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor.
Immunohistochemical detection of 8-OHdG by use of the 1F7 monoclonal antibody in oligomer-treated PC3 prostate cancer cells. a, control untreated peripheral.

Immunohistochemical detection of 8-OHdG by use of the 1F7 monoclonal antibody in oligomer-treated PC3 prostate cancer cells. a, control untreated peripheral.
Activating mutation of Ras is associated with CDCP1 expression in NSCLC. A, NSCLC cell lines with Ras + B-Raf mutations and wild-type Ras were examined.

Activating mutation of Ras is associated with CDCP1 expression in NSCLC. A, NSCLC cell lines with Ras + B-Raf mutations and wild-type Ras were examined.
Immunohistochemical analyses of SHH expression levels in nonmalignant prostate and adenocarcinoma tissues. Immunohistochemical analyses of SHH expression.

Immunohistochemical analyses of SHH expression levels in nonmalignant prostate and adenocarcinoma tissues. Immunohistochemical analyses of SHH expression.
BRCA1 promoter methylation detected in the peripheral blood and corresponding tumor. BRCA1 promoter methylation detected in the peripheral blood and corresponding.

BRCA1 promoter methylation detected in the peripheral blood and corresponding tumor. BRCA1 promoter methylation detected in the peripheral blood and corresponding.
TFAP2A knockdown inhibits tumor growth in vivo.

TFAP2A knockdown inhibits tumor growth in vivo.
Correlation of RSPO expression to LGR5 expansion in gastric cancer.

Correlation of RSPO expression to LGR5 expansion in gastric cancer.
Geographic colocalization of PD-L1+ tumor cells with infiltrating immune cells in MCC. The predominant pattern of tumor cell PD-L1 expression is at the.

Geographic colocalization of PD-L1+ tumor cells with infiltrating immune cells in MCC. The predominant pattern of tumor cell PD-L1 expression is at the.

Similar presentations

Ads by Google